Buffett's Berkshire Hathaway adds Activision Blizzard stake, exits Teva

Feb. 14, 2022 4:35 PM ETActivision Blizzard, Inc. (ATVI), TEVABRK.B, BRK.A, NU, CVX, FND, BMY, ABBV, RPRX, MRK, LSXMABy: Liz Kiesche, SA News Editor221 Comments

Warren Buffett Testifies Before Senate Finance Committee

Alex Wong/Getty Images News

  • Warren Buffett's Berkshire Hathaway (NYSE:BRK.B) (NYSE:BRK.A) took new stakes in Activision Blizzard (NASDAQ:ATVI) at 14.7M shares and in Nu Holdings (NYSE:NU) at 107M shares during the last quarter of 2021, according to its latest 13F filing.
  • The investment firm divested its stake in pharmaceutical company Teva (NYSE:TEVA).
  • Increased its stakes in Chevron (NYSE:CVX) to 38.2M shares from 28.7M shares and in Floor & Decor Holdings (NYSE:FND) to ~844K from ~817K.
  • Reduced stakes in Bristol-Myers Squibb (NYSE:BMY) to 5.20M shares from 22.0M shares, in AbbVie (NYSE:ABBV) to 3.03M shares from 14.4M shares, and in Royalty Pharma (NASDAQ:RPRX) to ~8.65M shares from ~13.1M shares.
  • In Q3, Berkshire added Royalty Pharma (RPRX) and exited Merck (NYSE:MRK).

Recommended For You

Comments (221)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.